Helping you make better health choices

In shops now or delivered to your home from only £3.50 an issue!

Subscribe!

Fat profits

CommunityBlogsBryan Hubbard2011JulyFat profits

Search

About

Bryan Hubbard is Publisher and co-editor of WDDTY. He is a former Financial Times journalist. He is a Philosophy graduate of London University. Bryan is also the author of several books, including The Untrue Story of You and Secrets of the Drugs Industry.

Archive

2014

2013

2012

2011

2010

2009

2008

2007

2006

Fat profits

July 11th 2011, 13:03 |
4,218 views

The cancer at the heart of medicine is its need to serve two masters: the patient and the pharmaceutical company's shareholders. In an ideal capitalist system, this does not necessarily present a problem. The very best drugs will become the most popular because they are the most beneficial, and so the company and its shareholders are rewarded.

Unfortunately, medicine does not operate as a free market. The patient-or consumer, to use market-speak-does not have a choice. Instead, the doctor, as the expert, makes the purchasing decision-often based on the flimsiest evidence or none at all.

And because this expert channel to the market exists, the drug company exploits it. It funds 'research' that is little more than PR, it arranges 'conferences' in exotic locales, it 'sponsors' the doctor's surgery with free PCs and other gadgetry. It also pays the doctor to participate in 'early-stage marketing trials'-a good way to get a new drug launched.

Truth and the scientific method become distorted. Ultimately, they are harnessed to enhance a drug's sales and so reward the shareholders. Truth plays second fiddle to profits in a market that is controlled. The best product doesn't always win, but the one that is best supported just might.

When you have billions of pounds and dollars of drug company revenues at stake, you have a problem. When you have two powerful industry groups involved, you have a black hole from which truth cannot escape-so great is the pull for profit.

This has happened with the cholesterol theory, the subject of our cover story this month. It claims that if you eat a diet that is high in fats, you will increase the level of LDL or 'bad' cholesterol in your system. This 'bad' cholesterol will stick to your artery walls until they become clogged, thus causing a heart attack.

This theory has created two massive markets: statin drugs, the most profitable drug sector in the world; and the low-fat industry, which also generates billions of pounds and dollars every year.

The cholesterol theory is not true; it has been disproven many times by the scant amount of independent research that is allowed to see the light of day. Worse, new research is demonstrating that 'bad' cholesterol isn't bad at all-it plays a key role in healing inflammation and, ironically, in preventing heart attacks.

As we age, cholesterol becomes even more important. It helps to build muscle and keeps our brains sharp. The attack on 'bad' cholesterol could be behind the rise in dementia in the elderly, and may be causing the very thing it is supposed to protect us from.

But when it comes to profits or people, guess which comes first.

Latest Tweet

About

Since 1989, WDDTY has provided thousands of resources on how to beat asthma, arthritis, cancer, depression and many other chronic conditions.

Start by looking in our fully searchable database, active and friendly community forums and the latest health news.

Positive SSL Wildcard

Facebook Twitter

Most Popular Health Website of the Year 2014

© 2010 - 2016 WDDTY Publishing Ltd.
All Rights Reserved